Recognizing the need to pursue research into the causes, a treatment, and an eventual cure for idiopathic pulmonary fibrosis, supporting the goals and ideals of National Idiopathic Pulmonary Fibrosis Awareness Week, and for other purposes.
The source supplies the latest action, but no lifecycle stage.
Latest action (18 Oct 2007): Message on Senate action sent to the House.
What this bill does
This House Concurrent Resolution, H.Con.Res. 182, would express Congress's recognition of the need for research into the causes, treatment, and cure of idiopathic pulmonary fibrosis (IPF). It would also support the establishment and goals of National Idiopathic Pulmonary Fibrosis Awareness Week, aiming to increase public understanding of this serious lung disorder.
The resolution highlights that IPF is a progressive, incurable lung disease causing scarring and irreversible loss of lung tissue function. It notes the condition affects over 128,000 Americans, with a significant increase in mortality and a median survival rate of 2 to 3 years. The bill emphasizes the need to raise awareness and improve detection of IPF and other forms of pulmonary fibrosis.
Introduced in the House of Representatives in July 2007, the bill was referred to the Committee on Energy and Commerce. The latest action indicates that a message concerning Senate action on the resolution was sent to the House in October 2007. As a concurrent resolution, it requires passage by both the House and Senate to be enacted, serving as a statement of congressional sentiment rather than a law with binding force.
Plain-English summary generated by Bill100 AI from the official record. Always verify against the source below.
Timeline
18 Oct 2007
Message on Senate action sent to the House.
18 Oct 2007
Message on Senate action sent to the House.
Common questions
- What does H.Con.Res. 182 do?
- This House Concurrent Resolution, H.Con.Res. 182, would express Congress's recognition of the need for research into the causes, treatment, and cure of idiopathic pulmonary fibrosis (IPF). It would also support the establishment and goals of National Idiopathic Pulmonary Fibrosis Awareness Week, aiming to increase public understanding of this serious lung disorder. The resolution highlights that IPF is a progressive, incurable lung disease causing scarring and irreversible loss of lung tissue function. It notes the condition affects over 128,000 Americans, with a significant increase in mortality and a median survival rate of 2 to 3 years. The bill emphasizes the need to raise awareness and improve detection of IPF and other forms of pulmonary fibrosis. Introduced in the House of Representatives in July 2007, the bill was referred to the Committee on Energy and Commerce. The latest action indicates that a message concerning Senate action on the resolution was sent to the House in October 2007. As a concurrent resolution, it requires passage by both the House and Senate to be enacted, serving as a statement of congressional sentiment rather than a law with binding force.
- Has H.Con.Res. 182 become law?
- The source does not supply a confirmed lifecycle stage for H.Con.Res. 182. Check the latest action and official source below.
- Who sponsored H.Con.Res. 182?
- H.Con.Res. 182 was sponsored by Rep. Deal, Nathan [R-GA-9] (R-GA), with 48 cosponsors.
- What's the latest action on H.Con.Res. 182?
- Message on Senate action sent to the House. (18 Oct 2007).
Related bills in Commemorations
Honoring the members of the United States Air Force who were killed in the June 25, 1996, terrorist bombing of the Khobar Towers United States military housing compound near Dhahran, Saudi Arabia.
Recognizing the historical significance of Juneteenth Independence Day, and expressing the sense of Congress that history should be regarded as a means for understanding the past and more effectively facing the challenges of the future.
Honoring the life of each of the 9 fallen City of Charleston firefighters who lost their lives in Charleston, South Carolina, on June 18, 2007.
Supporting the goals and ideals of African American Bone Marrow Awareness Month.
Bill100 mirrors the public U.S. legislative record from Congress.gov and GovTrack and adds plain-English AI summaries. It is an information tool, not legal, compliance or lobbying advice, and it is not affiliated with the U.S. Congress or any government agency. AI summaries can simplify or omit detail — every bill links to the official source; verify there before you rely on it.